By Brendan Pierson (Reuters) -Arkansas's attorney general on Wednesday accused drugmakers and pharmacy benefit managers of colluding to drive up the price of insulin drugs, the...
Last week, Danish pharmaceutical company Novo Nordisk announced its first quarter earnings beating estimates, raising its growth outlook for the rest of 2022 and expanding its...
By Ahmed Aboulenein WASHINGTON (Reuters) - U.S. lawmakers attempting to cut the cost of insulin for more than a million Americans to $35 per month are unlikely to succeed as...
Despite Wall Street’s ongoing bearish sentiment, new exchange-traded funds (ETF) have continued to reach the market in impressive numbers in 2022. ETFs listed in the US...
Exchange-traded funds (ETFs) have been gaining popularity in recent years and as investors' appetite grows for these investment instruments, asset managers are converting more and...
For Immediate ReleaseChicago, IL – November 18, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts...
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Buy | Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Buy | Strong Buy |
| Summary | Strong Buy | Strong Buy | Strong Buy | Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 425.08 | 425.39 | 409.00 | +47.12 | +12.47% | 2.76M | NASDAQ | |||
| 35.18 | 35.87 | 34.96 | -0.35 | -0.99% | 11.41M | NASDAQ | |||
| 137.21 | 143.70 | 127.00 | +8.75 | +6.81% | 7.48M | NYSE | |||
| 1.46 | 1.469 | 1.41 | +0.110 | +8.15% | 23.04K | NASDAQ | |||
| 583.28 | 585.46 | 560.01 | +32.62 | +5.92% | 3.66M | NASDAQ | |||
| 256.17 | 259.22 | 247.74 | +14.93 | +6.19% | 1.34M | NYSE | |||
| 5.67 | 5.95 | 5.53 | 0.00 | 0.00% | 0.00 | NASDAQ | |||
| 51.60 | 52.83 | 50.45 | +0.58 | +1.14% | 3.95M | NASDAQ | |||
| 84.05 | 84.33 | 82.52 | +2.12 | +2.59% | 1.85M | NYSE | |||
| 70.06 | 70.62 | 68.80 | +1.03 | +1.49% | 2.30M | NYSE | |||
| 5.33 | 5.44 | 5.25 | -0.030 | -0.56% | 1.88M | NYSE | |||
| 24.46 | 24.76 | 24.46 | +0.10 | +0.41% | 82.67K | NYSE | |||
| 8.96 | 9.065 | 8.87 | +0.020 | +0.22% | 167.48K | NASDAQ | |||
| 12.90 | 12.956 | 12.29 | +0.122 | +0.95% | 800.45K | NYSE | |||
| 48.63 | 48.66 | 48.19 | +0.21 | +0.43% | 1.93M | NYSE |